Patents by Inventor Kristin Patterson

Kristin Patterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatments with nirogacestat
    Patent number: 11957662
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Grant
    Filed: October 20, 2023
    Date of Patent: April 16, 2024
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Treatments with nirogacestat
    Patent number: 11951096
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Grant
    Filed: October 20, 2023
    Date of Patent: April 9, 2024
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Treatments with nirogacestat
    Patent number: 11938116
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Grant
    Filed: October 20, 2023
    Date of Patent: March 26, 2024
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20240091197
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: October 20, 2023
    Publication date: March 21, 2024
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Treatments with nirogacestat
    Patent number: 11925619
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Grant
    Filed: July 30, 2023
    Date of Patent: March 12, 2024
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Treatments with nirogacestat
    Patent number: 11925620
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Grant
    Filed: October 20, 2023
    Date of Patent: March 12, 2024
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20240066007
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 29, 2024
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240058307
    Abstract: The present disclosures are directed to chlorinated tetralin compounds and pharmaceutical compositions.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 22, 2024
    Inventors: Kristin PATTERSON, Mark HATCHER
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20240058305
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 22, 2024
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20240050410
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 15, 2024
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20240050411
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 15, 2024
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20240033251
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: July 30, 2023
    Publication date: February 1, 2024
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
    Patent number: 11884610
    Abstract: The present disclosure relates to: a) crystalline forms of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide; b) pharmaceutical compositions comprising one or more crystalline forms of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, one or more pharmaceutically acceptable carriers; c) methods of treating a tumor a cancer, or a Rasopathy disorder by administering one or more crystalline forms of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide to a subject in need thereof; and methods of producing essentially pure Form IV of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: January 30, 2024
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Kristin Patterson, Jiping Liu, Ricky Wayne Couch, Peter Gregory Varlashkin, Mai Li, Yonghong Gan
  • Treatments with nirogacestat
    Patent number: 11872211
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Grant
    Filed: May 19, 2023
    Date of Patent: January 16, 2024
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Chlorinated tetralin compounds and pharmaceutical compositions
    Patent number: 11844780
    Abstract: The present disclosures are directed to chlorinated tetralin compounds and pharmaceutical compositions.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: December 19, 2023
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Kristin Patterson, Mark Hatcher
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20230372300
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: May 19, 2023
    Publication date: November 23, 2023
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • TREATMENTS WITH NIROGACESTAT
    Publication number: 20230372301
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: May 19, 2023
    Publication date: November 23, 2023
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Chlorinated tetralin compounds and pharmaceutical compositions
    Patent number: 11807611
    Abstract: The present disclosures are directed to chlorinated tetralin compounds and pharmaceutical compositions.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: November 7, 2023
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Kristin Patterson, Mark Hatcher
  • DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2- FLUORO-4-IODO-PHENYLAMINO)-BENAZMIDE AND USES THEREOF
    Publication number: 20230330047
    Abstract: The present disclosure relates to dispersible pharmaceutical compositions comprising N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, a pharmaceutically acceptable carrier.
    Type: Application
    Filed: January 9, 2023
    Publication date: October 19, 2023
    Applicant: SpringWorks Therapeutics, Inc.
    Inventors: Kristin PATTERSON, Jiping LIU
  • Fluorinated phenylamino compounds and pharmaceutical compositions
    Patent number: 11780800
    Abstract: The present disclosure relates to fluorinated phenylamino compounds, their pharmaceutical compositions, and methods for treating one or more tumors or cancers selected from the group consisting of plexiform neurofibromas (PN), plexiform neurofibromas associated with neurofibromatosis type 1 (NF1-PN), cutaneous neurofibromas (cNF), pancreatic ductal adenocarcinoma (PDAC), high grade glioma (HGG), low grade ovarian cancer, tuberous sclerosis (TSC), Langerhans cell histiocytosis (LCH), brain cancer, and a cancer that has metastasized to a patient's brain, comprising administering to a patient in need thereof, those pharmaceutical compositions.
    Type: Grant
    Filed: March 16, 2023
    Date of Patent: October 10, 2023
    Assignee: SPRINGWORKS THERAPEUTICS, INC.
    Inventors: Kristin Patterson, Piero L Ruggiero